Post by
Photoman77 on Sep 14, 2021 3:23pm
ARISTOTLE is better than GRAIL to detect early cancers
https://news.harvard.edu/gazette/story/2020/03/in-clinical-study-blood-test-can-detect-range-of-cancers/
"In a study involving thousands of participants, a new blood test (Grail) detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute, a Harvard affiliate, and the Mayo Clinic."
Here is the problem ^^
39 percent sensitivity for patients with stage I cancer
69 percent sensitivity for those with stage II cancer
83 percent sensitivity for those with stage III cancer
92 percent sensitivity for those with stage IV cacner
39% stage 1 is terrible for Grail! That's worse that a grade F in school.
Aristotle is far superior with over 90% accuracy at this stage for most common cancers
Grail for 8 billion dolalrs lol!
Comment by
4real4ever on Sep 14, 2021 7:20pm
**From Tripp's statement** **And your article has 1 1/2 year old. This kind on CEO make BIG progress in 1 1/2 year instead of others**
Comment by
Nailbiter1 on Sep 14, 2021 9:30pm
This post has been removed in accordance with Community Policy
Comment by
Teddy3 on Sep 14, 2021 10:14pm
Smart people who could actually read scientific papers and have inside knowledge of cancer and blood testing would be buying large amounts of this stock for cheap if so, trust me.
Comment by
Teddy3 on Sep 14, 2021 10:15pm
And if for some reason I am wrong and SZLS does have a great product but still can't sell it or generate any interest, let that be an indictment on Tripp ability to lead a company.